Joseph Feczko, MD was until May 2009, senior vice president and chief medical officer (CMO) of Pfizer Inc and member of the executive leadership team with global responsibilities for all aspects of the company's medical, regulatory, and safety activities. He is board certified (U.S.) in internal medicine and infectious diseases. Following a time in private practice, he joined Pfizer in 1982 in New York. He then worked for ten years in the United Kingdom for both Pfizer and Glaxo where his responsibilities included supervising clinical research, regulatory affairs, data management, and safety reporting. He returned to Pfizer in New York in 1996 where he held positions of increasing responsibility in clinical research, regulatory affairs, and safety, culminating in the role of CMO.

He is currently a member of the board of directors for the Foundation for the National Institutes of Health, the New York Academy of Medicine, and Research!America. In addition to serving as a member of the board of directors of Accordia Global Health Foundation, Dr. Feczko is also a member of the Technical Expert Committee for Trachoma on the International Trachoma Initiative of the Task Force for Global Health. He is currently chairman of the board of directors of Cardoz Pharmaceuticals AB (Stockholm, Sweden), a member of the board of directors of Keryx Biopharmaceuticals, Inc. (New York), a member of the supervisory board of Amsterdam Molecular Therapeutics based in The Netherlands, and a member of the board of directors of ChemoCentryx, Inc. He was previously a member of the governing board of the Technology Strategy Board of the United Kingdom.

<< Return to Board of Directors